Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Collegium Pharmaceutical Inc. logo

Collegium Pharmaceutical Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

40.91
 
USD
  
0.98
  
(2.45%)
Optionable: Yes  Market Cap: 1,276 M  90-day average vol: 449,478

Previous close: 39.93  Open: 40.1  Bid: 40.92  Ask: 43.17
52 week range    
20.83   
   40.91
Peers   
AGRX / 
HZNP / 
UTHR / 
Last updated: Thursday 28th March 2024
60
MarketXLS Rank
55
Value
76
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

COLL Income Statement

Annual
Invalid dateDec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquisitionExpense15 M
Amortization of intangibles-397000.0-258000.0-110 M15 M61 M67 M134 M134 M
Basic EPS from continuing operations-1.48-0.680.782.05-0.741.43
Basic EPS total-1.48-3.880.27-0.680.782.05-0.741.43
Basic weighted shares outstanding14 M24 M30 M33 M33 M34 M35 M34 M34 M
Cost of sales-213000.0-3 M-166 M194 M130 M126 M254 M241 M
Depreciation-171000.0-258000.0-336000.0-1 M731000.0870000.02 M3 M3 M
DepreciationAndAmortization-171000.0-258000.0-336000.0-1 M731000.0870000.02 M3 M3 M
Diluted EPS total-0.46-3.88-2.47-1.19-0.680.761.86-0.741.29
Diluted normalized net income/share-0.460.761.86-0.741.29
Diluted weighted shares outstanding21 M24 M30 M34 M35 M41 M34 M42 M
GainOnSaleOfPPE280000.0102000.096000.01 M141000.0
GainOnSaleOfSecurity2 M232000.012000.01 M16 M
GeneralAndAdministrativeExpense19 M-25 M-194000.0116 M114 M119 M172 M159 M
Gross operating profit1 M26 M115 M103 M180 M151 M209 M326 M
Income before tax-27 M-94 M-75 M-39 M-23 M28 M-3 M-29 M76 M
Income restructuring and M&A5 M
Income taxes830000.0-75 M-4 M28 M
Interest income-439000.05 M6 M
InterestExpenseNonOperating439000.094000.020 M909000.029 M21 M63 M83 M
MarketingExpense-16 M-11 M-17 M
MinorityInterests87 M
MiscOtherSpecialCharges91000.020000.028 M280 M-24 M
Net income from total operations-27 M-94 M-75 M-39 M-23 M27 M72 M-25 M48 M
NetIncomeCommonStockholders-27 M-94 M-75 M-39 M-23 M27 M72 M-25 M48 M
NetIncomeContinuousOperations-27 M-94 M-75 M-39 M-23 M27 M72 M-25 M48 M
NetIncomeDiscontinuousOperations905000.0
NetNonOperatingInterestIncomeExpense-439000.0-94000.0582000.0-18 M-909000.0-29 M-21 M-63 M-83 M
Normalized income60 M
Operating income-27 M-94 M-75 M-21 M-24 M56 M18 M33 M167 M
Operating income before depreciation (EBITDA)-27 M-94 M-74 M92 M-6 M127 M90 M182 M316 M
OperatingExpense27 M96 M101 M-135 M127 M124 M133 M176 M159 M
Other income net-91000.0-20000.0-28 M-280 M-2 M-232000.0-12000.0-1 M8 M
OtherGandA19 M-25 M-194000.0116 M114 M119 M172 M159 M
OtherImpairmentOfCapitalAssets-2 M
OtherOperatingExpenses-27 M-96 M-57000.0-64000.0-76000.0-36000.0-67000.0176 M159 M
OtherTaxes61 M
ProvisionForGainLossOnDisposal905000.0
RentAndLandingFees-112000.0-182000.0-194000.0
Research & development expense8 M15 M9 M9 M10 M10 M9 M4 M
ResearchExpense8 M15 M9 M9 M10 M10 M9 M4 M
RestructringAndMnAIncome5 M
Revenue per share-397000.0-258000.0-110 M30 M61 M67 M134 M134 M
SalariesAndWages-6 M-8 M-14 M17 M22 M24 M23 M27 M
Selling Gen & administrative expense19 M81 M93 M127 M116 M114 M119 M172 M159 M
SellingAndMarketingExpense81 M93 M127 M
SellingExpense81 M93 M127 M
Special income/charges-5 M
Total Income available for interest expense (EBIT)-27 M-94 M-75 M-19 M-22 M56 M18 M34 M159 M
Total common shares outstanding24 M29 M33 M33 M34 M35 M33 M34 M32 M
Total net income-27 M-94 M-75 M-39 M-23 M27 M72 M-25 M48 M
Total ordinary shares32 M32 M32 M32 M32 M32 M32 M32 M32 M
Total revenues2 M28 M280 M297 M310 M277 M464 M567 M
TotalExpenses27 M95 M99 M-301 M320 M254 M259 M431 M400 M
TotalRevenue2 M28 M280 M297 M310 M277 M464 M567 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University